| Literature DB >> 30918830 |
Emily Frith1, Pradeep Y Ramulu2, Bimal Ashar3, Paul D Loprinzi1.
Abstract
BACKGROUND: The purpose of this study was to comprehensively examine the association of a multitude of individual medical conditions, as well as multimorbidity, on work status among a national sample of U.S. adults.Entities:
Keywords: Chronic disease; Employment; Epidemiology; Multimorbidity
Year: 2019 PMID: 30918830 PMCID: PMC6425902 DOI: 10.15280/jlm.2019.9.1.15
Source DB: PubMed Journal: J Lifestyle Med ISSN: 2234-8549
NHANES cycles utilized and available data for each of the evaluated medical conditions*
| Medical/Health Condition | NHANES Cycles Evaluated | Unweighted Sample Size for | Unweighted Sample Size for | Weighted Proportion (%) for | Age Range of Participants |
|---|---|---|---|---|---|
| Depression | 2005–2012 | 14,762 | 1,450 | 7.9 | 20–64 |
| Arthritis | 1999–2012 | 28,119 | 4,946 | 17.3 | 20–64 |
| Asthma | 1999–2012 | 28,119 | 3,729 | 13.6 | 20–64 |
| Bronchitis | 1999–2012 | 28,119 | 1,457 | 5.5 | 20–64 |
| Cancer (of any type) | 1999–2012 | 28,119 | 1,316 | 5.5 | 20–64 |
| Congestive Heart Failure | 1999–2012 | 28,119 | 426 | 1.1 | 20–64 |
| Coronary Artery Disease | 1999–2012 | 28,119 | 512 | 1.6 | 20–64 |
| Diabetes | 1999–2012 | 28,119 | 2,185 | 5.7 | 20–64 |
| Emphysema | 1999–2012 | 28,119 | 307 | 1.1 | 20–64 |
| Liver Disease | 1999–2012 | 28,119 | 953 | 3.1 | 20–64 |
| Sleep Disorder | 2005–2012 | 17,136 | 1,289 | 7.7 | 20–64 |
| Stroke | 1999–2012 | 28,119 | 510 | 1.4 | 20–64 |
| Age-Related Macular Degeneration | 2005–2008 | 3,633 | 119 | 3.1 | 40–64 |
| Visual Impairment | 1999–2008 | 17,033 | 146 | 0.7 | 20–64 |
| Cardiorespiratory Fitness | 1999–2004 | 3,300 | 550 | 15.4 | 20–49 |
| Chronic Obstructive Pulmonary Disease | 2007–2010 | 5,499 | 580 | 11.5 | 20–64 |
| Hearing Impairment | 1999–2010 | 4,510 | 1,395 | 31.3 | 20–64 |
| Non-Proliferative Retinopathy | 2005–2008 | 3,655 | 395 | 8.3 | 40–64 |
| Obesity | 1999–2012 | 26,593 | 9,511 | 33.4 | 20–64 |
| Underweight | 1999–2012 | 26,593 | 451 | 1.8 | 20–64 |
| Peripheral Arterial Disease | 1999–2004 | 4,063 | 541 | 11.4 | 40–64 |
| Peripheral Neuropathy | 1999–2004 | 4,701 | 514 | 9.0 | 40–64 |
| Physical Inactivity | 2003–2006 | 4,339 | 2,365 | 50.7 | 20–64 |
| Chronic Kidney Disease | 1999–2012 | 25,247 | 515 | 1.8 | 20–64 |
| Elevated C-Reactive Protein | 1999–2010 | 21,532 | 8,480 | 35.1 | 20–64 |
| Elevated Fasting Glucose | 1999–2012 | 12,429 | 1,045 | 5.9 | 20–64 |
| Elevated LDL Cholesterol | 1999–2012 | 11,744 | 1,381 | 11.5 | 20–64 |
| Elevated Total Cholesterol | 1999–2012 | 25,304 | 3,772 | 14.6 | 20–64 |
| Elevated Triglycerides | 1999–2012 | 12,309 | 2,071 | 15.1 | 20–64 |
| Low HDL Cholesterol | 1999–2012 | 25,304 | 5,088 | 20.5 | 20–64 |
| Hypertension | 1999–2012 | 25,661 | 3,596 | 12.3 | 20–64 |
| Smoking (cotinine) | 2003–2012 | 18,778 | 5,937 | 31.5 | 20–64 |
Estimates in this table are after excluding participants with missing work status data and those between 20 and 74 years of age (only those 20 yrs and older were eligible for the medical condition survey).
Represents the unweighted sample size for the evaluated variable (e.g., 33,095 participants provided data for having arthritis [yes/no]) across the available NHANES cycles.
Represents the unweighted sample size for having the evaluated medical condition. For example, 7,342 had a physician diagnosis of arthritis. For medical conditions with multiple categories (e.g., no retinopathy, mild retinopathy, and moderate or greater retinopathy), this sample size estimate is the number of participants with any degree of the impairment/condition (e.g., mild or moderate+ retinopathy).
Represents the weighted proportion of column “c”, i.e., the proportion of Americans with any degree of the evaluated impairment/condition.
Assessment and classification of the evaluated medical conditions
| Medical Condition | Description of Assessment | Definition of Categories |
|---|---|---|
| Depression | Patient Health Questionnaire (PHQ-9) | Moderate or greater depression defined as PHQ-9 ≥ 10 |
| Age-Related Macular Degeneration | Canon Non-Mydratic Retinal Camera CR6-45NM | Early AMD: presence of drusen and/or pigmentary abnormalities; late AMD: presence of choroidal neovascularization and/or geographic atrophy; few participants had late AMD, so participants were classified as early/late AMD |
| Visual Impairment | ARK-760 autorefractor | Participants with presenting visual acuity of 20/40 or better in either eye were classified as having normal sight. Participants with presenting visual acuity worse than 20/40, but postrefraction visual acuity in either eye were 20/40 or better, were classified as having uncorrected refractive error. Participants with visual acuity worse than 20/40 after autorefraction, or who self-reported not being able to see light with both eyes open, were classified as having visual impairment. |
| Cardiorespiratory Fitness | Treadmill-based submaximal test. | Low fitness: < 20th percentile; moderate fitness: 20–59th percentile; high fitness ≥ 60th percentile for age and gender. |
| Chronic Obstructive Pulmonary Disease | Objective pulmonary function testing using Ohio 822/827 dry-rolling seal volume spirometers | GOLD classifications when FEV1/FVC < 0.70: Mild COPD: FEV1 ≥ 80% predicted; Moderate: 50% ≤ FEV1 < 80% predicted; Severe: 30% ≤ FEV1 < 50% predicted; Very severe: FEV1 < 30% predicted; few participants had very severe COPD, so classifications were mild, moderate, and severe COPD. |
| Hearing Impairment | Calculating the average of air conduction pure-tone thresholds; low pure-tone average (LPTA) and high pure-tone average (HPTA). | Hearing within normal limits (LPTA & HPTA ≤ 25 dB), mild hearing loss (LPTA or HPTA 26–40 dB) and moderate or greater hearing loss (LPTA or HPTA > 40 dB) |
| Non-Proliferative Retinopathy | Canon Non-Mydratic Retinal Camera CR6-45NM | No retinopathy, mild non-proliferative retinopathy, moderate-to-severe non-proliferative retinopathy; based on presence of 1 or more retinal microaneurysms or retinal blot hemorrhages using the Early Treatment Diabetic Retinopathy Study grading criteria. |
| Weight Status | Measured body mass index | Obesity defined as ≥ 30 kg/m2 |
| Peripheral Arterial Disease | Ankle Brachial Index (ABI) from measured upper and lower extremity blood pressure assessment. | Normal ABI (1–1.4) and abnormal ABI (< 1 or > 1.4) |
| Peripheral Neuropathy | 5.07 Semmes-Weinstein nylon monofilament | Peripheral neuropathy defined as at least 1 insensate area in either foot. |
| Physical Inactivity | Accelerometry over a 7-day period, and only including those providing at least 4 days of 10+ hrs/day of monitoring. | Physical inactivity defined as engaging in < 150 min/wk of accelerometer-determined moderate-to-vigorous physical activity (1-min bouts). |
| Chronic Kidney Disease | Glomerular filtration rate was assessed from the CKD Epidemiology equation based on specified race, sex, and creatinine level. | < 60 mL/min per 1.73 m2 |
| Elevated C-Reactive Protein (CRP) | Latex-enhanced nephelometry. | > 0.3 mg/dL |
| Elevated Fasting Glucose | Hexokinase method | ≥ 126 mg/dL |
| Elevated LDL Cholesterol | Friedewald formula | ≥ 160 mg/dL |
| Elevated Total Cholesterol | Measured enzymatically in serum using the Roche Hitachi method. | > 240 mg/dL |
| Elevated Triglycerides | Measured enzymatically in serum. | ≥ 200 mg/dL |
| Low HDL Cholesterol | Measured enzymatically in serum. | < 40 mg/dL |
| Hypertension | Measured systolic and diastolic blood pressure; average of 3–4 measurements. | ≥ 140 mmHg systolic or ≥ 90 mmHg diastolic |
| Smoking (cotinine) | Serum cotinine, a biological measure of smoking status, was measured by an isotope dilution-high performance liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry. | Serum cotinine levels of > 1.78 ng/mL for men and > 4.47 ng/mL for women were assessed to differentiate smokers from non-smokers |
Multivariable logistic regression analyses* predicting odds of not working, working part-time, and being unemployed
| Medical/Health Condition Based on Cumulative Index Rating Scale (CIRS) Morbidity Classes | Not Working vs. Working | Part Time vs. Full Time | Unemployed vs. Working | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
| ||||||||
| Entire Sample | Men | Women | Entire Sample | Entire Sample | ||||||
| Cardiac | ||||||||||
| Congestive Heart Failure vs. none | 2.14 | < 0.001 | 2.50 | < 0.001 | 1.72 | 0.01 | 1.09 | 0.73 | 1.02 | 0.94 |
| Coronary Artery Disease vs. none | 1.75 | < 0.001 | 1.57 | 0.003 | 1.86 | 0.01 | 1.06 | 0.81 | 1.36 | 0.27 |
| Vascular | ||||||||||
| Peripheral Arterial Disease vs none | 1.58 | < 0.001 | 1.41 | 0.03 | 1.64 | 0.002 | 0.87 | 0.52 | 1.72 | 0.02 |
| Hypertension vs none | 1.16 | 0.005 | 1.22 | 0.006 | 1.11 | 0.14 | 1.08 | 0.28 | 0.98 | 0.89 |
| Stroke vs. none | 2.83 | < 0.001 | 2.40 | < 0.001 | 3.24 | < 0.001 | 1.62 | 0.07 | 1.58 | 0.07 |
| Respiratory | ||||||||||
| Asthma vs. none | 1.00 | 0.86 | 1.10 | 0.27 | 0.97 | 0.67 | 1.07 | 0.19 | 1.01 | 0.90 |
| Bronchitis vs. none | 1.21 | 0.005 | 1.37 | 0.01 | 1.21 | 0.02 | 1.05 | 0.63 | 1.14 | 0.35 |
| Emphysema vs. none | 2.32 | < 0.001 | 2.56 | 0.001 | 1.91 | 0.005 | 1.37 | 0.30 | 1.46 | 0.35 |
| Chronic Obstructive Pulmonary Disease | ||||||||||
| Mild vs. no COPD | 1.17 | 0.26 | 1.13 | 0.53 | 1.19 | 0.51 | 1.47 | 0.01 | 0.84 | 0.56 |
| Moderate vs. no COPD | 1.36 | 0.06 | 1.40 | 0.10 | 1.28 | 0.30 | 1.22 | 0.40 | 1.01 | 0.97 |
| Severe vs. no COPD | 2.84 | 0.01 | 3.35 | 0.08 | 2.22 | 0.20 | 0.62 | 0.57 | 3.55 | 0.07 |
| Ophthalmological | ||||||||||
| Age-Related Macular Degeneration | ||||||||||
| Early/Late AMD vs. none | 1.12 | 0.69 | 0.83 | 0.66 | 1.43 | 0.37 | 1.37 | 0.45 | 1.88 | 0.07 |
| Non-Proliferative Retinopathy | ||||||||||
| Mild vs. none | 0.97 | 0.88 | 0.88 | 0.52 | 1.05 | 0.83 | 0.78 | 0.27 | 0.69 | 0.15 |
| Moderate/severe vs. none | 2.03 | 0.17 | 2.85 | 0.16 | 1.58 | 0.29 | 0.18 | 0.05 | 0.48 | 0.40 |
| Visual Impairment | ||||||||||
| Uncorrected refractive error vs. normal sight | 1.24 | 0.008 | 1.47 | 0.01 | 1.07 | 0.53 | 1.27 | 0.02 | 1.27 | 0.14 |
| Visual impairment vs. normal sight | 2.68 | < 0.001 | 1.53 | 0.28 | 4.49 | < 0.001 | 1.39 | 0.46 | 0.39 | 0.14 |
| Hepatic | ||||||||||
| Liver Disease vs. none | 1.47 | < 0.001 | 1.59 | < 0.001 | 1.32 | 0.03 | 0.96 | 0.81 | 1.27 | 0.23 |
| Renal | ||||||||||
| Chronic Kidney Disease vs. none | 1.87 | < 0.001 | 1.93 | < 0.001 | 1.88 | < 0.001 | 1.40 | 0.13 | 0.76 | 0.42 |
| Musculoskeletal | ||||||||||
| Arthritis vs. none | 1.55 | < 0.001 | 1.85 | < 0.001 | 1.41 | < 0.001 | 1.11 | 0.15 | 1.22 | 0.02 |
| Neurological | ||||||||||
| Hearing Impairment | ||||||||||
| Mild vs none | 1.19 | 0.17 | 1.33 | 0.15 | 1.17 | 0.37 | 1.03 | 0.85 | 1.47 | 0.10 |
| Moderate+ vs. none | 1.46 | 0.002 | 1.74 | 0.002 | 1.18 | 0.37 | 1.05 | 0.79 | 1.16 | 0.53 |
| Peripheral Neuropathy vs none | 1.38 | 0.04 | 1.44 | 0.11 | 1.25 | 0.29 | 1.45 | 0.03 | 0.61 | 0.12 |
| Endocrine/Metabolic | ||||||||||
| Diabetes vs. none | 1.53 | < 0.001 | 1.71 | < 0.001 | 1.39 | < 0.001 | 1.01 | 0.92 | 1.31 | 0.08 |
| Obesity vs not obese | 1.06 | 0.09 | 1.05 | 0.24 | 1.07 | 0.11 | 0.87 | 0.007 | 1.08 | 0.29 |
| Underweight vs. not underweight | 1.62 | 0.001 | 1.83 | 0.01 | 1.51 | 0.003 | 1.25 | 0.17 | 1.47 | 0.08 |
| Elevated C-Reactive Protein vs. not | 1.25 | < 0.001 | 1.35 | < 0.001 | 1.18 | < 0.001 | 1.02 | 0.70 | 1.04 | 0.56 |
| Elevated Glucose vs. not | 1.35 | 0.002 | 1.24 | 0.09 | 1.24 | 0.14 | 0.89 | 0.47 | 1.03 | 0.86 |
| Elevated LDL Cholesterol vs. not | 1.10 | 0.25 | 0.89 | 0.41 | 1.31 | 0.02 | 1.07 | 0.54 | 1.30 | 0.07 |
| Elevated Total Cholesterol vs. not | 1.18 | < 0.001 | 0.99 | 0.95 | 1.37 | < 0.001 | 1.11 | 0.09 | 1.35 | 0.002 |
| Elevated Triglycerides vs. not | 1.37 | < 0.001 | 1.14 | 0.18 | 1.70 | < 0.001 | 1.03 | 0.76 | 1.17 | 0.19 |
| Low HDL Cholesterol vs. not | 1.20 | < 0.001 | 1.10 | 0.12 | 1.40 | < 0.001 | 0.88 | 0.07 | 1.03 | 0.67 |
| Cancer (of any type) vs. not | 1.33 | 0.002 | 1.63 | < 0.001 | 1.22 | 0.07 | 1.00 | 0.94 | 1.31 | 0.10 |
| Psychiatric | ||||||||||
| Moderate+ Depression vs. Less Depression Symptoms | 3.12 | < 0.001 | 4.23 | < 0.001 | 2.60 | < 0.001 | 1.31 | 0.06 | 1.76 | < 0.001 |
| Behavioral | ||||||||||
| Sleep Disorder vs. none | 1.25 | 0.003 | 1.03 | 0.73 | 1.41 | 0.003 | 1.12 | 0.33 | 0.94 | 0.75 |
| Cardiorespiratory Fitness | ||||||||||
| Low vs. high | 1.09 | 0.48 | 1.13 | 0.59 | 1.13 | 0.45 | 0.83 | 0.31 | 1.06 | 0.74 |
| Moderate vs. high | 0.87 | 0.25 | 0.85 | 0.33 | 0.91 | 0.63 | 0.84 | 0.13 | 0.78 | 0.28 |
| Physical Activity | ||||||||||
| Inactive vs. active | 1.93 | < 0.001 | 2.62 | < 0.001 | 1.46 | 0.01 | 1.09 | 0.38 | 1.33 | 0.10 |
| Smoker vs. non-smoker | 1.39 | < 0.001 | 1.45 | < 0.001 | 1.33 | < 0.001 | 1.07 | 0.24 | 1.23 | 0.01 |
Separate logistic regression models were computed for employment status (not working vs. working; part-time vs. full-time; and unemployed vs. working).
For the self-report of physician diagnosis variables, 1 model was computed which included all conditions in the model, plus the covariates age, gender, and race-ethnicity. The exception to this was the sleep disorder variable because sleep disorder assessment did not occur across all NHANES cycles. Therefore, the ORs for the sleep variable is from a separate model that included sleep disorder plus the other medical conditions and covariates.
Separate models were computed for each of the laboratory-determined variables not all participants had data on all biomarkers. In each model covariates included age, gender, and race-ethnicity.
The examination-determined variables were not all collected during the same cycles; therefore, separate models were computed for each of these examination-determined medical conditions. Covariates age, gender, and race-ethnicity were included in each model.
Working is defined as working at an outside job or business within the last week; full time is defined as ≥ 35 hrs/wk; and unemployed is defined as looking for work or on a layoff.
Fig. 1Conditions significantly associated with higher odds of not working. CAD, coronary artery disease; CHF, congestive heart failure; CKD, chronic kidney disease; CRP, C-reactive protein; PAD, peripheral arterial disease. Medical conditions organized based on Cumulative Index Rating Scale (CIRS) Morbidity Classes.
Fig. 2Proportion of American adults not working based on the degree of multimorbidity.